Najah Sampson/LinkedIn
Mar 3, 2026, 14:04
Najah Sampson: Understanding Key Risk Factors and Symptoms of VTE
Najah Sampson, US Internal Medicine Lead at Pfizer, shared on LinkedIn:
”Blood clots: a serious health concern we don’t talk about enough
Blood clots are often overlooked—but they can have serious consequences if missed.
Increasing awareness of how common they are, along with understanding key risk factors and symptoms, can make all the difference in early recognition.
- Recognize the signs
- Know the risks
- Take action
Awareness saves lives.
Let’s keep this conversation going and empower people with the knowledge they need to act early.”
Stay updated with Hemostasis Today.
-
Jun 4, 2026, 16:17Nada Fahd: Immune Thrombocytopenia (ITP) – Outpatient vs Inpatient Management
-
Jun 4, 2026, 16:16Saoud Hassan: Hemostasis and Blood Coagulation Pathway – Simplified
-
Jun 4, 2026, 16:15Farooq Khan: Vacuuming Blood Clots in Seconds
-
Jun 4, 2026, 16:14Kayla Garrett: Confirming Or Excluding APS Relies On Accurate Lupus Anticoagulant Testing
-
Jun 4, 2026, 16:14Scott Colton: Exploring the Key Differences Between Anticoagulant and Antiplatelet Medications
-
Jun 4, 2026, 16:13Wolfgang Miesbach: Is Bone Health a Silent Comorbidity In Haemophilia and VWD?
-
Jun 4, 2026, 15:35Carolina La Mura: Insights from the LATAM Hemophilia Forum 2026
-
Jun 4, 2026, 15:25Heba Youssef: Anticoagulation Bridging – A Clinical Summary Every Practitioner Should Know
-
Jun 4, 2026, 15:10Dipanjana Datta: Genetic Spectrum of Hemophilia and Carrier Screening in Families of Persons with Hemophilia